Matches 1 - 50 out of 358 1 2 3 4 5 6 7 8 >


Match Document Document Title
US20140056962 DRUG DELIVERY SYSTEM  
The subject invention provides a drug delivery system comprising at least one compartment comprising (i) a drug-loaded thermoplastic polymer core layer, (ii) a drug-loaded thermoplastic polymer...
US20130022674 PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME  
A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising...
US20090137538 METHOD OF TREATING ATROPHIC VAGINITIS  
This invention relates to a method and pharmaceutical composition useful in treating a condition responsive to hormone replacement therapy. Specifically, the invention is related to the long term...
US20050004002 Compositions and methods of delivery of pharmacological agents  
The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human...
US20160213687 PROGESTERONE CONTAINING ORAL DOSAGE FORMS AND KITS  
The present invention provides for progesterone containing pharmaceutical oral dosage forms, pharmaceutical kits, and related methods. In one embodiment, an oral dosage form formulated for...
US20160067265 Abiraterone Acetate Formulation  
Pharmaceutical compositions, including unit dosage forms, comprising fine particle abiraterone acetate with or without an antioxidant and or a sequesting agent as well as methods for producing and...
US20150320682 NANOPARTICULATE MEGESTROL FORMULATIONS  
The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
US20130338122 TRANSDERMAL HORMONE REPLACEMENT THERAPIES  
Hormone replacement therapies are provided comprising solubilized progesterone alone and optionally with an estrogen, cyclic/sequential and continuous-combined dosing, and administered via...
US20130052263 PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE  
Pharmaceutical compositions with synchronized solubilizer release as well as various methods associated therewith, are disclosed and described. More specifically, the aqueous solubility of a drug...
US20110160168 MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS  
A formulation for drug delivery, providing enhanced modulation of solubility, stability, absorption, metabolism, and/or pharmacokinetic profile of a lipophilic therapeutic agent by formulation...
US20090142313 VAGINAL DELIVERY SYSTEM  
The present invention is related to an intravaginal delivery system for the controlled release of drospirenone and an estrogen, optionally also comprising one or more therapeutically active or a...
US20070111975 Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens  
The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days,...
US20070021396 Oral contraception with trimegestone  
The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the...
US20070009594 Compositions and methods for treatment of cycle-related symptoms  
Methods are provided for treating cycle-related symptoms through administration of at least one progestin and at least one estrogen to a female subject.
US20060009428 Cyclic progestin regimens and kits  
A method of contraception is provided which involves delivery of 21 to 27 consecutive days of a progestin in the absence of an estrogen or other steroidal compound, followed by 1 to 7 days without...
US20160082017 ESTRIOL THERAPY FOR MULTIPLE SCLEROSIS AND OTHER AUTOIMMUNE DISEASES  
The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, more particularly, Th1-mediated (cell-mediated) autoimmune diseases including:...
US20140302115 DRUG DELIVERY SYSTEM BASED ON POLYETHYLENE VINYLACETATE COPOLYMERS  
A drug delivery system consisting of one or more compartments and comprising a progestogenic compound dissolved in a thermoplastic polyethylene vinylacetate copolymer whereby, if the delivery...
US20130089574 METHOD OF PREVENTIVE ON-DEMAND HORMONAL CONTRACEPTION  
The invention relates to a method of hormonal female controlled on-demand contraception in which a pharmaceutical preparation comprising at least one progestogen is administered transdermally on...
US20120220556 DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY  
A pharmaceutical composition comprising as a first active ingredient an estrogen, such as estradiol or estradiol valerate, in sufficient amounts to treat disorders and symptoms associated with...
US20100266705 NANOPARTICULATE MEGESTROL FORMULATIONS  
The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
US20100093679 DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY  
A pharmaceutical composition comprising as a first active ingredient an estrogen, such as estradiol or estradiol valerate, in sufficient amounts to treat disorders and symptoms associated with...
US20090269403 ORAL CONTRACEPTIVE DOSAGE FORMS AND METHODS OF MAKING SUCH DOSAGE FORMS  
Disclosed herein are oral dosage forms and methods of their use, in particular oral dosage systems for the delivery of drugs for use as a female oral contraceptive. In an embodiment, an oral...
US20070111976 Method of preventive on-demand hormonal contraception  
The invention relates to a method of hormonal female controlled on-demand contraception in which a pharmaceutical preparation comprising at least one progestogen is administered transdermally on...
US20150224117 NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES  
Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized...
US20150018320 Hormone Containing Emulsion Comprising Krill Phospholipids  
The invention relates to hormone containing oil-in-water emulsion for parenteral administration comprising progestogen and/or estrogen; a phospholipid comprising one or two omega-3 fatty acid...
US20120178726 NOVEL COMPOUNDS  
The present invention provides compounds of formula (I) wherein n, p, R1, R2, X1, X2, X3, X4, X5, R3a, R3b, R4, R5 and R6 are as defined in the specification, a process for their preparation,...
US20120028936 ORAL CONTRACEPTION WITH TRIMEGESTONE  
The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the...
US20100285097 VAGINAL DELIVERY SYSTEM  
The present invention is related to an intravaginal delivery system for the controlled release of drospirenone and an estrogen, optionally also comprising one or more therapeutically active or a...
US20100279989 ORAL CONTRACEPTION WITH TRIMEGESTONE  
The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the...
US20080182828 Low Dose Estrogen Interrupted Hormone Replacement Therapy  
A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three...
US20060058272 Pharmaceutical composition for use as a contraceptive  
A pharmaceutical composition comprises, as a first active agent, 6β,7β;15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbol actone (drospirenone) in an amount corresponding to a daily dosage, on...
US20050272712 Compositions and methods for treatment of premenstrual dysphoric disorder  
The present invention relates to a method for treating premenstrual dysphoric disorder through administration of at least one progestin and at least one estrogen to a female subject.
US20050245492 Use of equol for treating skin diseases  
Equol (7-hydroxy-3(4′hydroxyphenyl)-chroman), the major metabolite of the phytoestrogen daidzein, specifically binds and blocks the hormonal action of 5α-dihydrotestosterone (DHT) in vitro and in...
US20170008920 MAMMALIAN METABOLITES OF STEROIDS  
Described herein, in certain embodiments, are steroidal derivatives, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using...
US20160089381 STABILITY OF PROGESTOGEN FORMULATIONS  
In a preparation for hormone replacement therapy having a low content of progestogen, the stability of the progestogen component can be enhanced by using a cellulosic binder, for example...
US20140050794 PHARMACEUTICAL COMPOSITION FOR USE AS A CONTRACEPTIVE  
A pharmaceutical composition comprises, as a first active agent, 6β,7β;15β,16β-dimethene-3-oxo-17α-pregn-4-ene-21,17-carbolac tone (drospirenone) in an amount corresponding to a daily dosage, on...
US20110003748 Method of treatment and compositions of D-chiro inositol and phosphates thereof  
The present invention relates to the use of D-chiroinositol or a phosphate thereof in combination with folate for the reduction or prevention of congenital deformations such as anorectal...
US20100330168 PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE AND USES THEREOF  
Novel pharmaceutical compositions contain micronized progesterone and at least one oleic safflower oil referred to as safflower oil type II, and medicines comprising said compositions are useful...
US20070275940 Composition containing Vitamin D and phytoestrogens  
The present invention relates to compositions and methods for preventing the development of epithelial ovarian cancer by administering compounds in an amount capable of regulating TGF-β expression...
US20060257472 Stability of progestogen formulations  
In a preparation for hormone replacement therapy having a low content of progestogen, the stability of the progestogen component can be enhanced by using a cellulosic binder, for example...
US20060135496 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens  
The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days,...
US20150352126 NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES  
Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized...
US20150037395 TRANSDERMAL HORMONE DELIVERY SYSTEM: COMPOSITIONS AND MTEHODS  
A transdermal hormone delivery system (THDS) is disclosed. The THDS is useful for control of fertility and as therapy for a variety of diseases and conditions treatable by robust delivery of...
US20140296128 MATERIALS AND METHODS FOR TREATMENT OF CANCER AND IDENTIFICATION OF ANTI-CANCER COMPOUNDS  
The subject invention pertains to the treatment of tumors and cancerous tissues and the prevention of tumorigenesis and malignant transformation through the modulation of JAK/STAT3 intracellular...
US20120329765 MEDICINAL TARGETED LOCAL LIPOLYSIS  
Aqueous phospholipid systems comprising at least one phospholipid, at least one bile acid and water are suitable for producing medicaments for the treatment of adipose tissue disorders and lead to...
US20110135719 PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD AND USES THEREOF  
The present invention relates to a pharmaceutical composition comprising micronized progesterone, soya bean lecithin, and at least one oil selected from the group consisting of sunflower oil,...
US20110124611 METHODS OF HORMONAL TREATMENT UTILIZING CONTRACEPTIVE REGIMENS WITH CONTINUOUS ESTROGEN ADMINISTRATION  
The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The...
US20100317631 Gel Composition and Transcrotal Application of a Composition for the Treatment of Hypogonadism  
The present invention relates to a gel composition on alcoholic basis, comprising at least one androgenic steroid and at least one C3-C4 diol as enhancer, as well as the use of a composition...
US20090005351 Hormone replacement therapy  
This invention relates to methods and pharmaceutical compositions for providing hormone replacement therapy in perimenopausal, menopausal, and postmenopausal women through the continuous...
US20080175908 TABLET-IN-TABLET COMPOSITIONS  
The present invention is directed to tablet-in-tablet compositions comprising one or more estrogens in a first layer and a therapeutic agent in a second layer, and processes for their preparation

Matches 1 - 50 out of 358 1 2 3 4 5 6 7 8 >